Risks and benefits of azathioprine therapy
- PMID: 16009676
- PMCID: PMC1774869
- DOI: 10.1136/gut.2004.053231
Risks and benefits of azathioprine therapy
Abstract
The risk of lymphoma may be increased by about fourfold in patients with inflammatory bowel disease treated with thiopurines. The increased risk could be a result of the medications, the severity of the underlying disease, or a combination of the two.
Comment on
-
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.Gut. 2005 Aug;54(8):1121-5. doi: 10.1136/gut.2004.049460. Gut. 2005. PMID: 16009685 Free PMC article.
References
-
- Loftus E, Tremaine W, Habermann T. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000;95:2308–12. - PubMed
-
- Bernstein C, Blanchard J, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854–62. - PubMed
-
- Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn’s disease. Gastroenterology 1990;98:1123–8. - PubMed
-
- Besson H, Renaudier P, Merrill RM, et al. Smoking and non-Hodgkins lymphoma: a case-control study in the Rhone-Alpes region of France. Cancer Causes Control 2003;14:381–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical